OBLN - Obalon Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Obalon Therapeutics's activity chart (see below) currently has 0 price targets and 6 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by KYLE ROSE from CANACCORD on 22-May-2019. First documented stock forecast 11-Nov-2016.

Best performing analysts who are covering OBLN - Obalon Therapeutics:

Kyle Rose Rick Wise

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

7 years 3 months 20 days ago
(22-May-2019)

0/1 (0%)

$6.83 (67.16%)

Hold

7 years 6 months 17 days ago
(25-Feb-2019)

0/1 (0%)

$7.83 (76.99%)

Show more analysts

Please expand the browser size to see the chart

Which analyst most recently updated their price target on OBLN (Obalon Therapeutics)?

Kyle Rose

Which analyst has the current lower performing score on OBLN (Obalon Therapeutics) with a proven track record?

RICK WISE

Which analyst has the most public recommendations on OBLN (Obalon Therapeutics)?

Kyle Rose has 12 price targets and 11 ratings on OBLN

Which analyst is the currently most bullish on OBLN (Obalon Therapeutics)?

Rick Wise with the highest potential upside of $0

Which analyst is the currently most reserved on OBLN (Obalon Therapeutics)?

Kyle Rose with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?